ChronoScale Holdings Corp - 8-K Filing

ChronoScale completes sale of Ekso Bionics business unit and announces $1B annualized revenue run-rate from new AI infrastructure agreements (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 7.01 Regulation FD Disclosure Press Release On October 1, 2026, the Company issued a press release announcing the sale of Ekso and the expansion o, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $EKSO

Read the full article at SEC EDGAR

More Regulatory news